Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-58.49%
operating margin TTM
-55.8%
revenue TTM
163.85 Million
revenue per share TTM
6.04$
valuation ratios | |
|---|---|
| pe ratio | -3.24 |
| peg ratio | 0.07 |
| price to book ratio | 1.09 |
| price to sales ratio | 1.90 |
| enterprise value multiple | -6.77 |
| price fair value | 1.09 |
profitability ratios | |
|---|---|
| gross profit margin | 105.33% |
| operating profit margin | -55.8% |
| pretax profit margin | -58.49% |
| net profit margin | -58.49% |
| return on assets | -23.52% |
| return on equity | -31.57% |
| return on capital employed | -27.72% |
liquidity ratio | |
|---|---|
| current ratio | 4.67 |
| quick ratio | 4.67 |
| cash ratio | 3.62 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 10.48 |
| days of payables outstanding | -356.19 |
| cash conversion cycle | 366.67 |
| receivables turnover | 34.82 |
| payables turnover | -1.02 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.08 |
| debt equity ratio | 0.12 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.11 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -2.09 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.21 |
| cash per share | 8.78 |
| operating cash flow per share | -2.21 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -2.09 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) reported earnings?
Arcturus Therapeutics Holdings Inc. (ARCT) published its most recent earnings results on 07-11-2024.
What is Arcturus Therapeutics Holdings Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)'s trailing twelve months ROE is -31.57%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Arcturus Therapeutics Holdings Inc. (ARCT) currently has a ROA of -23.52%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ARCT's net profit margin stand at?
ARCT reported a profit margin of -58.49% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ARCT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.67 in the most recent quarter. The quick ratio stood at 4.67, with a Debt/Eq ratio of 0.12.